Gates Medical Research Institute
Clinical trials sponsored by Gates Medical Research Institute, explained in plain language.
-
New TB combo drug trial aims to shorten treatment
Disease control Recruiting nowThis study tests whether a new drug called TBD09, when used with other TB medicines, is safe and works well in adults with drug-sensitive tuberculosis (TB). About 150 people will take part. The main goals are to see how quickly the drug combination kills TB bacteria and to check …
Phase: PHASE2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could vitamin B3 help beat TB? new trial launches
Disease control Recruiting nowThis phase 2 trial tests whether adding nicotinamide (a form of vitamin B3) to a standard three-drug regimen can safely and effectively treat drug-susceptible pulmonary tuberculosis. About 165 adults with newly diagnosed TB will receive one of two doses of nicotinamide plus the s…
Phase: PHASE2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC